Asthma

SENA Health Announces Partnership with Inspira Health to Support Hospital-Level Care in the Home

Retrieved on: 
Tuesday, March 5, 2024
Urinary tract infection, Hospital, Physician, HOME, Health, United States Senate, Asthma, ED, Cellulitis, Pneumonia, Vital signs, CHF, Chronic obstructive pulmonary disease, Heart failure, Home, Observation, Medicare, Patient, UTI, Senate, COPD, Partnership

PHILADELPHIA, March 5, 2024 /PRNewswire/ -- SENA Health announces its partnership with Inspira Health to support patients receiving Healing at Home clinical services. The home-based services deliver advanced-level care to eligible Inspira Health patients in the comfort of their own homes. The program combines expert care with advanced technology to offer a seamless, integrated service that maximizes health outcomes.

Key Points: 
  • PHILADELPHIA, March 5, 2024 /PRNewswire/ -- SENA Health announces its partnership with Inspira Health to support patients receiving Healing at Home clinical services.
  • The home-based services deliver advanced-level care to eligible Inspira Health patients in the comfort of their own homes.
  • "Inspira Health sets itself apart as a truly innovative and forward-thinking organization in the region," said Dr. Anthony Wehbe, Founder and CEO of SENA Health.
  • Inspira Health, in collaboration with SENA, has recently obtained the CMS Acute Hospital Care at Home Waiver.

Breathe Change: Lung Health Foundation Launches First of Three Landmark Policy Forums on Thursday, March 7

Retrieved on: 
Monday, March 4, 2024
Chairperson, Clinical Practice, RSV, Education, Building, Spirometry, Hospital, Overalls, Asthma, Pneumonia, Assembly, Hope, LHF, Long-term care, Climate change, Patient, Policy, Health policy, Lung cancer, Health professional, Diagnosis, Wildfire, Mortality, Public, Research, Radon, Health insurance

LHF is the nation's leading non-profit organization dedicated to supporting and empowering individuals living with lung conditions across Canada.

Key Points: 
  • LHF is the nation's leading non-profit organization dedicated to supporting and empowering individuals living with lung conditions across Canada.
  • The session showcases the best-of-the-best in COPD and lung disease research, diagnosis and treatment modalities, and policy initiatives.
  • Dawn Bowdish, Executive Director, Firestone Institute for Respiratory Health and Dr. Maya de Zoysa, Respirologist, West Nipissing General Hospital.
  • For those navigating the labyrinth of lung disease, LHF offers an expansive array of disease-specific support programs and resources.

NPCA Finds Air Pollution Harms 97% of National Parks

Retrieved on: 
Monday, March 4, 2024
Federal Transit Administration, Love, Air pollution, Atmosphere, Ozone, Drought, National Park Service, Climate, Asthma, National Parks Conservation Association, Nature, Risk, Wilderness, Interim, Health, Climate change, Mammoth Cave National Park, Haze, NPCA, Wildfire, National park, Renewable energy

WASHINGTON, March 4, 2024 /PRNewswire/ -- A 2024 report by the National Parks Conservation Association found that 97% of parks have unsatisfactory levels of visibility impairment overall, indicating they are far from achieving clean air or clear skies. This finding, drawn from National Park Service data, encapsulates three categories evaluated in NPCA's report: Hazy Skies, Unhealthy Air and Harm to Nature. 98% of national parks in the United States grapple with concerning levels of haze pollution, obscuring the scenic views and landmarks that draw millions of visitors each year. The report shows that 96% of these parks face concerning levels of ozone pollution, increasing health risks, such as respiratory illnesses and asthma attacks, for staff, visitors and nearby communities. And it underscores that 96% of national parks harbor sensitive species and natural habitats adversely affected by pollution.

Key Points: 
  • And it underscores that 96% of national parks harbor sensitive species and natural habitats adversely affected by pollution.
  • Responding to this alarming reality, the report also outlines ways NPCA has led efforts to urge the implementation of time-tested, effective programs like the Regional Haze Rule , the strengthening of national air standards, improved air monitoring in and around national parks and lastly, the advancement of climate-friendly policies.
  • Visitors to national parks expect clean air and clear skies whether they are visiting stunning wilderness landscapes or urban monuments.
  • As iconic landscapes standing on the frontlines of the climate crisis, NPCA emphasizes the urgent need to cut the air pollution driving climate change and safeguard national parks for future generations.

SafeDose Adds Pediatric Education Resources to its Acute Care Medication Safety Software

Retrieved on: 
Tuesday, February 27, 2024
EDS, Hospital, Sepsis, BSN, Nursing, Multimedia, Shock, RN, Education, Croup, ENPC, Asthma, Anaphylaxis, Bronchiolitis, ED, Curriculum, Patient, Seizure, Premium, PALS

SOUTHBOROUGH, Mass., Feb. 27, 2024 /PRNewswire-PRWeb/ -- SafeDose®, a pioneer in the safe, simple, and standardized delivery of pediatric medication in acute care settings, has added a comprehensive set of educational tools which can be used to train nurses who care for pediatric patients in emergency settings. The Pediatric Education Resources package is included with the Premium subscription offering for the SafeDose drug administration software suite.

Key Points: 
  • SOUTHBOROUGH, Mass., Feb. 27, 2024 /PRNewswire-PRWeb/ -- SafeDose®, a pioneer in the safe, simple, and standardized delivery of pediatric medication in acute care settings, has added a comprehensive set of educational tools which can be used to train nurses who care for pediatric patients in emergency settings.
  • The Pediatric Education Resources package is included with the Premium subscription offering for the SafeDose drug administration software suite.
  • The SafeDose Pediatric Education Resources include comprehensive simulation planners, quick visual in-service sheets, and brief videos on where to find further point-of-care and educational content within the SafeDose software.
  • This bundle includes access to the asthma section within the SafeDose software, asthma Readiness Resources, and asthma Education Resources.

LG OUTFITS 2024 'NEW AMERICAN HOME' WITH SMART LIFE SOLUTIONS

Retrieved on: 
Tuesday, February 27, 2024
Emerald, HVAC, National Association, Dust, Steam, News, VRF, NAHB, Season, Man cave, History, Certification, KBIS, EPA, Television, Atmosphere, Smith, Official, Electronics, Atmosphere of Earth, The New American, LG Electronics, Variable refrigerant flow, LG, Pollen, Clothing, Allergen, Asthma, New American, Great room, Las Vegas Convention Center, Las Vegas Strip, Home Energy Rating, OLED, UHD, IBS, Consumer electronics

LAS VEGAS, Feb. 27, 2024 /PRNewswire/ -- Advanced HVAC solutions, smart home appliances and consumer electronics from LG Electronics are delivering high performance, unparalleled home connectivity, enhanced convenience and energy efficiency to The New American Home® (TNAH®), official show home of the 2024 NAHB International Builders' Show® (IBS). The National Association of Home Builders (NAHB) chose LG as Platinum Partner for this year's featured "Net Zero" luxury home in the Nevada desert outside of Las Vegas.

Key Points: 
  • NAHB Selects LG HVAC Solutions, Home Appliances and Consumer Electronics for Official IBS 2024 Net-Zero Showcase Home
    LAS VEGAS, Feb. 27, 2024 /PRNewswire/ -- Advanced HVAC solutions, smart home appliances and consumer electronics from LG Electronics are delivering high performance, unparalleled home connectivity, enhanced convenience and energy efficiency to The New American Home® ( TNAH ®), official show home of the 2024 NAHB International Builders' Show® (IBS).
  • LG smart life solutions featured in TNAH 2024 – from heat-pump-enabled laundry and home comfort systems to efficient TVs, induction cooking and ENERGY STAR® certified appliances – reflect LG's commitment to environmental sustainability and underscore the company's support for builders' increasing focus on high-performance homes.
  • TNAH 2024 is designed to exceed the requirements for certification to the Emerald level of the National Green Building Standard™ .
  • Smart LG appliances in TNAH 2024 deliver added convenience with advanced technologies and come equipped with elevated design and sleek styling packages.

New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies

Retrieved on: 
Sunday, February 25, 2024
Bangladesh Technical Education Board, AAAAI, Johns Hopkins Children's Center, Research, Food allergy, Hazelnut, NIH, FDA, Immunoglobulin E, Rheumatology, NEJM, Life, Risk, Annual general meeting, Safety, Milk, Fear, Associate, Patient, Novartis, Asthma, Food, Face, American Academy, Pharmaceutical industry

Safety findings were consistent with the known safety profile of Xolair across its approved indications and in previous clinical trials4.

Key Points: 
  • Safety findings were consistent with the known safety profile of Xolair across its approved indications and in previous clinical trials4.
  • The US Food and Drug Administration (FDA) recently approved the expanded use of Xolair in children and adults with IgE-mediated food allergies based on the OUtMATCH data.
  • "While allergic reactions to exposures are common and often severe, there have been limited treatment advancements for food allergy.
  • The results of the OUtMATCH study showed that anti-IgE therapy could significantly reduce the occurrence of allergic reactions across multiple foods in the event of an accidental exposure."

Omalizumab Increases the Reaction Threshold for Peanut and Other Common Food Allergies

Retrieved on: 
Sunday, February 25, 2024
Infection, Anxiety, AAAAI, Research, Food allergy, Multimedia, NIAID, MD, NIH, Quality of life, Immunoglobulin E, Asthma, Novartis, Annual general meeting, Genentech, Roche, Patient, Journal, Food, American Academy

WASHINGTON, Feb. 25, 2024 /PRNewswire-PRWeb/ -- Sixteen weeks of omalizumab results in a higher tolerated threshold for multiple food allergies according to new research presented today at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting and published in the New England Journal of Medicine.

Key Points: 
  • "Food allergies affect millions of individuals in the U.S., and those impacted face a daily threat of life-threatening reactions.
  • To remain safe, constant vigilance is required and even then, accidental exposures are very common," said Dr. Robert A.
  • "The OUtMATCH study demonstrated that omalizumab (Xolair) significantly increased the threshold for reaction in most patients for peanut and the six other foods studied, enough to provide real protection against small, accidental exposures.
  • As food allergies are common, this study highlights a valuable option for safe and effective food allergy treatment.

Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024

Retrieved on: 
Sunday, February 25, 2024
Allergy, Ophthalmology, AAAAI, Omalizumab, Upper respiratory tract infection, Dermatology, Allergic rhinitis, Season, Hematology, Rhinitis, Immunology, Patient, Autoimmunity, Clinical trial, PPP, SOC, Asthma, Insurance, American Academy, Pharmaceutical industry

The presentation of the poster titled "A Phase II study of LP-003, a novel high-affinity, long-acting anti-IgE antibody for allergic rhinitis" by Longbio Pharma marked a significant moment during the conference.

Key Points: 
  • The presentation of the poster titled "A Phase II study of LP-003, a novel high-affinity, long-acting anti-IgE antibody for allergic rhinitis" by Longbio Pharma marked a significant moment during the conference.
  • This Phase II study shows that 100mg LP-003 significantly improved nasal symptoms (TNSS score) of uncontrolled seasonal allergic rhinitis patients despite SoC treatment.
  • We are honored to unveiled the exciting Phase II results of LP-003, the first registrational clinical trial of anti-IgE antibody for AR conducted in China."
  • As Longbio Pharma charts its course forward, the successful Phase II study of LP-003 in allergic rhinitis represents a pivotal milestone in advancing the treatment landscape for allergic diseases.

Government of Canada announces draft rules to cut pollutants that cause smog in communities across Canada

Retrieved on: 
Friday, February 23, 2024
Air pollution, Atmosphere, Health Canada, Volatile organic compound, The Honourable, Research, Petroleum, Risk management, Release, Gasoline, Asthma, Anishinaabe, Canada Gazette, Climate change, Risk, Health, Benzene, VOC, Guilbeault, Smog, Death, Leukemia, Disease, Organic compound, Environment, Cancer, Oil

Today, Environment and Climate Change Canada and Health Canada announced the draft regulations to further reduce emissions from the petroleum sector of harmful volatile organic compounds (VOCs), which are airborne pollutants that contribute to smog.

Key Points: 
  • Today, Environment and Climate Change Canada and Health Canada announced the draft regulations to further reduce emissions from the petroleum sector of harmful volatile organic compounds (VOCs), which are airborne pollutants that contribute to smog.
  • These changes would improve air quality in neighbourhoods and communities across the country that are close to oil and gas facilities.
  • The draft regulations reflect an on-going commitment to environmental justice and the need to address disproportionate environmental harms on communities near industrial sites.
  • Exposure levels are higher in communities near large emission sources, including Indigenous and low-income communities already facing increased health burdens.

Friedman Introduces Consumer Watchdog Sponsored Bill to Hold Oil Drillers Financially Liable for Harm Caused by Their Drilling

Retrieved on: 
Wednesday, February 21, 2024
AB, Weapon, Nalleli Cobo, Sierra Club, Hearing, Multimedia, CALPIRG, Cancer, Birth, Food, Water, Pollution, Asthma, Parent, Assembly, Environment California, Risk, Consumer Watchdog, Health, Center for Biological Diversity, Legislation, Food & Water Watch, Environment, Community, Biodiversity

Under AB 3155, oil drillers could face penalties ranging from $250,000 to a $1 million.

Key Points: 
  • Under AB 3155, oil drillers could face penalties ranging from $250,000 to a $1 million.
  • These penalties can be challenged and rebutted by the drilling companies if the companies can prove the illnesses were caused another way.
  • Oil drillers that don't use the best technology to protect communities from toxic leaks need to be accountable to the communities they harm," said Assemblymember Friedman.
  • "If oil drillers don't want to invest in the most protective technology to drill, they should face legal accountability to the families they harm."